Increased heart rate variability in mice overexpressing the Cu/Zn superoxide dismutase

Free Radical Biology and Medicine

Volumn 45, Issue 4, 2008, Pages 396-403

  Thireau, Jérôme ^a   Poisson, Denise ^a   Zhang, Bei Li ^a   Gillet, Ludovic ^a   Le Pécheur, Marie ^b   Andres, Christian ^c   London, Jacqueline ^b   Babuty, Dominique ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

Antioxidant SOD1; Autonomic nervous system; Cardiac arrhythmias; Cholinesterase activity; Telemetry; Transgenic mice

Indexed keywords

ATROPINE; CARBACHOL; CHOLINESTERASE; COPPER ZINC SUPEROXIDE DISMUTASE; ISOPRENALINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTONOMIC NERVOUS SYSTEM; BIOASSAY; BRAIN STEM; BREATHING RATE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; MALE; MOUSE; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN FOLDING; SYMPATHETIC TONE;

ANIMALS; BRAIN STEM; CHOLINESTERASES; CIRCADIAN RHYTHM; FEMALE; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; SUPEROXIDE DISMUTASE;

MUS; MUS MUSCULUS;

EID: 46949096632     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.020     Document Type: Article

References (62)

1. Poli G., Leonarduzzi G., Biasi F., and Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 11 (2004) 1163-1182
2. Johnson F., and Giulivi C. Superoxide dismutases and their impact upon human health. Mol. Aspects Med. 26 (2005) 340-352
3. Fukuda K., Davies S.S., Nakajima T., Ong B.H., Kupershmidt S., Fessel J., Amarnath V., Anderson M.E., Boyden P.A., Viswanathan P.C., Roberts II L.J., and Balser J.R. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ. Res. 97 (2005) 1262-1269
4. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364 (1993) 362
5. Famulari A.L., Marschoff E.R., Llesuy S.F., Kohan S., Serra J.A., Dominguez R.O., Repetto M., Reides C., and Sacerdote de Lustig E. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls. J. Neurol. Sci. 141 (1996) 69-78
6. Groner Y., Elroy-Stein O., Avraham K.B., Schickler M., Knobler H., Minc-Golomb D., Bar-Peled O., Yarom R., and Rotshenker S. Cell damage by excess CuZnSOD and Down's syndrome. Biomed. Pharmacother. 48 (1994) 231-240
7. Gardiner K. Gene-dosage effects in Down syndrome and trisomic mouse models. Genome Biol. 5 (2004) 244
8. Pritchard M.A., and Kola I. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome. J. Neural Transm., Suppl. 57 (1999) 293-303
9. Groner Y., Lieman-Hurwitz J., Dafni N., Sherman L., Levanon D., Bernstein Y., Danciger E., and Elroy-Stein O. Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndrome. Ann. N. Y. Acad. Sci. 450 (1985) 133-156
10. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., and Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 8044-8048
11. Pastor M.C., Sierra C., Dolade M., Navarro E., Brandi N., Cabre E., Mira A., and Seres A. Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients. Clin. Chem. 44 (1998) 924-929
12. Sinet P.M., Lavelle F., Michelson A.M., and Jerome H. Superoxide dismutase activities of blood platelets in trisomy 21. Biochem. Biophys. Res. Commun. 67 (1975) 904-909
13. Holtzman D.M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D.J., Daniels S.E., Johnson R.M., Chen K., Sun Y., Carlson E., Alleva E., Epstein C.J., and Mobley W.C. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13333-13338
14. Anneren K.G., and Epstein C.J. Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts. Pediatr. Res. 21 (1987) 88-92
15. Baynard T., Pitetti K.H., Guerra M., and Fernhall B. Heart rate variability at rest and during exercise in persons with Down syndrome. Arch. Phys. Med. Rehabil. 85 (2004) 1285-1290
16. Guerra M., Llorens N., and Fernhall B. Chronotropic incompetence in persons with down syndrome. Arch. Phys. Med. Rehabil. 84 (2003) 1604-1608
17. Carpenter P.K. Cardiovascular and autonomic function in Down syndrome-prescribing implications. Br. J. Psychiatry 167 (1995) 118-119
18. Banks M.A., Jenson J., and Kugler J.D. Late development of atrioventricular block after congenital heart surgery in down syndrome. Am. J. Cardiol. 88 A7 (2001) 86-89
19. Le Pecheur M., Bourdon E., Paly E., Farout L., Friguet B., and London J. Oxidized SOD1 alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice. FEBS Lett. 579 (2005) 3613-3618
20. Colas D., London J., Cespuglio R., and Sarda N. Polysomnography in transgenic hSOD1 mice as Down syndrome model. J. Neural Transm., Suppl. (2003) 165-171
21. Lalonde R., Le Pecheur M., Strazielle C., and London J. Exploratory activity and motor coordination in wild-type SOD1/SOD1 transgenic mice. Brain Res. Bull. 66 (2005) 155-162
22. Jaarsma D., Haasdijk E.D., Grashorn J.A., Hawkins R., van Duijn W., Verspaget H.W., London J., and Holstege J.C. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7 (2000) 623-643
23. Paris D., Toyama K., Megarbane A., Casanova P.M., Sinet P.M., and London J. Rapid fluorescence in situ hybridization on interphasic nuclei to discriminate between homozygous and heterozygous transgenic mice. Transgenic Res. 5 (1996) 397-403
24. Thireau J., Zhang B.L., Poisson D., and Babuty D. Heart rate variability in mice: a theoretical and practical guide. Exp. Physiol. 93 (2008) 83-94
25. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., and Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75 (2000) 1320-1331
26. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
27. Andres C., Seidman S., Beeri R., Timberg R., and Soreq H. Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact. Neurochem. Int. 32 (1998) 449-456
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
29. Xing J., Yu Y., and Rando T.A. The modulation of cellular susceptibility to oxidative stress: protective and destructive actions of Cu,Zn-superoxide dismutase. Neurobiol. Dis. 10 (2002) 234-246
30. Nelson S.K., Bose S.K., and McCord J.M. The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic. Biol. Med. 16 (1994) 195-200
31. Pastore A., Tozzi G., Gaeta L.M., Giannotti A., Bertini E., Federici G., Digilio M.C., and Piemonte F. Glutathione metabolism and antioxidant enzymes in children with Down syndrome. J. Pediatr. 142 (2003) 583-585
32. Casado A., Lopez-Fernandez M.E., and Ruiz R. Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21. Clin. Chem. Lab Med. 45 (2007) 59-62
33. Perrone S., Longini M., Bellieni C.V., Centini G., Kenanidis A., De Marco L., Petraglia F., and Buonocore G. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin. Biochem. 40 (2007) 177-180
34. Lee M., Hyun D., Jenner P., and Halliwell B. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J. Neurochem. 76 (2001) 957-965
35. Nabarra B., Casanova M., Paris D., Nicole A., Toyama K., Sinet P.M., Ceballos I., and London J. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21). Lab. Invest. 74 (1996) 617-626
36. Kostrominova T.Y., Pasyk K.A., Van Remmen H., Richardson A.G., and Faulkner J.A. Adaptive changes in structure of skeletal muscles from adult Sod1 homozygous knockout mice. Cell Tissue Res. 327 (2007) 595-605
37. Mansier P., Clairambault J., Charlotte N., Medigue C., Vermeiren C., LePape G., Carre F., Gounaropoulou A., and Swynghedauw B. Linear and non-linear analyses of heart rate variability: a minireview. Cardiovasc. Res. 31 (1996) 371-379
38. Uechi M., Asai K., Osaka M., Smith A., Sato N., Wagner T.E., Ishikawa Y., Hayakawa H., Vatner D.E., Shannon R.P., Homcy C.J., and Vatner S.F. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha. Circ. Res. 82 (1998) 416-423
39. Gehrmann J., Hammer P.E., Maguire C.T., Wakimoto H., Triedman J.K., and Berul C.I. Phenotypic screening for heart rate variability in the mouse. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H733-H740
40. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93 (1996) 1043-1065
41. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Berger A.C., and Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213 (1981) 220-222
42. Malliani A. The pattern of sympathovagal balance explored in the frequency domain. News Physiol. Sci. 14 (1999) 111-117
43. Tankersley C.G., Campen M., Bierman A., Flanders S.E., Broman K.W., and Rabold R. Particle effects on heart-rate regulation in senescent mice. Inhal. Toxicol. 16 (2004) 381-390
44. Berul C.I., Maguire C.T., Gehrmann J., and Reddy S. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J. Interv. Cardiol. Electrophysiol. 4 (2000) 351-358
45. Fernhall B., McCubbin J.A., Pitetti K.H., Rintala P., Rimmer J.H., Millar A.L., and De Silva A. Prediction of maximal heart rate in individuals with mental retardation. Med. Sci. Sports Exerc. 33 (2001) 1655-1660
46. Shusterman V., Usiene I., Harrigal C., Lee J.S., Kubota T., Feldman A.M., and London B. Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H2076-2083
47. Kass D.A., Hare J.M., and Georgakopoulos D. Murine cardiac function: a cautionary tail. Circ. Res. 82 (1998) 519-522
48. Olanow C.W. Oxidation reactions in Parkinson's disease. Neurology 40 suppl (1990) 32-37 discussion 37-9
49. Zhu X., Smith M.A., Perry G., and Aliev G. Mitochondrial failures in Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 19 (2004) 345-352
50. Contestabile A., Fila T., Bartesaghi R., and Ciani E. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. J. Neurochem. 97 (2006) 515-526
51. Schallreuter K.U., Gibbons N.C., Zothner C., Elwary S.M., Rokos H., and Wood J.M. Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo. Biochem. Biophys. Res. Commun. 349 (2006) 931-938
52. Joaquim L.F., Farah V.M., Bernatova I., Fazan Jr. R., Grubbs R., and Morris M. Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H251-257
53. Mele J., Van Remmen H., Vijg J., and Richardson A. Characterization of transgenic mice that overexpress both copper zinc superoxide dismutase and catalase. Antioxid. Redox Signal. 8 (2006) 628-638
54. Abdollahi M., Mostafalou S., Pournourmohammadi S., and Shadnia S. Oxidative stress and cholinesterase inhibition in saliva and plasma of rats following subchronic exposure to malathion. Comp. Biochem. Physiol. C, Toxicol. Pharmacol. 137 (2004) 29-34
55. Jacobsson S.O., Cassel G.E., and Persson S.A. Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman-induced seizures. Arch. Toxicol. 73 (1999) 269-273
56. Ramkumar K.M., Latha M., Ashokkumar N., Pari L., and Ananthan R. Modulation of impaired cholinesterase activity in experimental diabetes: effect of Gymnema montanum leaf extract. J. Basic Clin. Physiol. Pharmacol. 16 (2005) 17-35
57. Bhatnagar A. Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ. Res. 76 (1995) 293-304
58. Page R.L., Tang A.S., and Prystowsky E.N. Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans. Circ. Res. 68 (1991) 1614-1620
59. Brigadeau F., Gele P., Marquie C., Soudan B., and Lacroix D. Ventricular arrhythmias following exposure of failing hearts to oxidative stress in vitro. J. Cardiovasc. Electrophysiol. 16 (2005) 629-636
60. Satoh N., Nishimura M., and Watanabe Y. Electrophysiologic alterations in the rabbit nodal cells induced by membrane lipid peroxidation. Eur. J. Pharmacol. 292 (1995) 233-240
61. Busciglio J., and Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378 (1995) 776-779
62. Iannello R.C., Crack P.J., de Haan J.B., and Kola I. Oxidative stress and neural dysfunction in Down syndrome. J. Neural Transm., Suppl. 57 (1999) 257-267